Edit |   |
---|---|
Antigenic Specificity | CD19, Human |
Clone | REA675 |
Host Species | Recombinant Human |
Reactive Species | human |
Isotype | IgG1 |
Format | VioBlue conjugate |
Size | 100 tests in 200 µL |
Concentration | 1:50 |
Applications | Flow cytometry |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | CD19 Antibody, anti-human, VioBlue®, REAfinity™. REA675 recognizes the human CD19 antigen, a type I transmembrane glycoprotein of 95 kDa that belongs to the immunglobulin superfamily. CD19 is expressed on B cells throughout most stages of B cell differentiation, though its expression is down-regulated during their terminal differentiation to plasma cells. Expression of CD19 is also found in the majority of B cell-derived malignancies. CD19 is further present on follicular dendritic cells. On B cells, CD19 associates with CD21, CD81, and CD225 (Leu-13) forming a signal transduction complex. | Additional information: Clone REA675 displays negligible binding to Fc receptors. |
Immunogen | n/a |
Other Names | B4, Leu-12 |
Gene, Accession # | Gene ID: 930 |
Catalog # | 130-120-031 |
Price | $355 |
Order / More Info | CD19, Human Antibody from MILTENYI BIOTEC B.V. & Co. KG |
Product Specific References | Nadler, L. M. et al. (1983) B4, a human B lymphocyte-associated antigen expressed on normal, mitogen-activated, and malignant B lymphocytes. J Immunol 131 (1): 244-250. | Fujimoto, M. et al. (2000) CD19 regulates intrinsic B lymphocyte signal transduction and activation through a novel mechanism of processive amplification. Immunol. Res. 22 (2-3): 281-298. | Poe, J. C. et al. (2001) CD19, CD21, and CD22: multifaceted response regulators of B lymphocyte signal transduction. Int. Rev. Immunol. 20 (6): 739-762. | Tedder, T. F. et al. (2002) CD19-CD21 complex regulates an intrinsic Src family kinase amplification loop that links innate immunity with B-lymphocyte intracellular calcium responses. Biochem. Soc. Trans. 30 (4): 807-811. |